109799 ⎘
dsDNA viruses; Details; Herpesviridae; Cytomegalovirus, e.g. human herpesvirus 5 Demonstrated effect
IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#2HUMAN CYTOMEGALOVIRUS VACCINE
#3POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USES THEREOF
#4IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#5HUMAN CYTOMEGALOVIRUS RNA VACCINES
#6VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE
#7Recombinant Cytomegalovirus Vectors As Vaccines For Tuberculosis
#8MITOCHONDRIAL DELIVERY OF RECOMBINANT NUCLEIC ACIDS
#9POXVIRUS-BASED VECTORS PRODUCED BY NATURAL OR SYNTHETIC DNA AND USES THEREOF
#10GENE THERAPY USING GENETICALLY MODIFIED VIRAL VECTORS
#11Human cytomegalovirus vaccine
#12Human cytomegalovirus vaccine
#13Tetanus toxoid and CCL3 improve DC vaccines
#14Recombinant cytomegalovirus vectors as vaccines for tuberculosis
#15VACCINE COMPOSITIONS OF HERPESVIRUS ENVELOPE PROTEIN COMBINATIONS TO INDUCE IMMUNE RESPONSE
#16IMMUNOTHERAPEUTIC COMPOSITIONS FOR TREATMENT OF GLIOBLASTOMA MULTIFORME
#17Human cytomegalovirus vaccine
#18Human cytomegalovirus RNA vaccines
#19Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules
#20Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
#21Human cytomegalovirus RNA vaccines
#22Human cytomegalovirus vaccine
#23Gene correction of SCID-related genes in hematopoietic stem and progenitor cells
#24Human cytomegalovirus gB polypeptide
#25Vaccine against beta-herpesvirus infection and use thereof
#26Recombinant HCMV and RHCMV vectors and uses thereof
#27Cationic oil-in-water emulsions
#28Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
#29Human cytomegalovirus RNA vaccines
#30Tetanus toxoid and CCL3 improve DC vaccines
#31Human cytomegalovirus RNA vaccines
#32Recombinant cytomegalovirus vectors as vaccines for tuberculosis
#33CMV ANTIGENS AND USES THEREOF
#34Cationic oil-in-water emulsions
#35Vaccine compositions comprising a saponin adjuvant
#36Tetanus toxoid and CCL3 improve DC vaccines
#37COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASES USING FOXP3
#38Compositions, methods and kits for eliciting an immune response
#39Recombinant HCMV and RHCMV vectors and uses thereof
#40Tripartite cancer theranostic nucleic acid constructs
#41Therapeutic Use of the Encoding Sequence of the Carboxy-Terminal Domain of the Heavy Chain of the Tetanus Toxin
#42VACCINE AGAINST BETA-HERPESVIRUS INFECTION AND USE THEREOF
#43Replicating recombinant adenovirus vectors, compositions, and methods of use thereof
#44Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
#45Vaccine compositions comprising a saponin adjuvant
#46Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
#47Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin
#48Pharmaceutical compositions containing 1-methyl-D-tryptophan
#49Vaccine Compositions Comprising a Saponin Adjuvant